Alimentary pharmacology & therapeutics

Keyphrases

Publications

volume 58, number 4, 2023

Carlos Moctezuma-Velazquez, Juan G Abraldes
Editorial: The use of Baveno VI and VII criteria in patients with hepatocellular carcinoma. Alimentary pharmacology & therapeutics 58 (4) (2023)
Manuel Romero, Matthew James Armstrong, Jesús Funuyet-Salas, Kamal Kant Mangla, Steen Ladelund, Anne-Sophie Sejling, Ichhya Shrestha, Arun J Sanyal
Editorial: Feeling better about NASH-Authors' reply. Alimentary pharmacology & therapeutics 58 (4) (2023)

volume 58, number 5, 2023

volume 58, number 6, 2023

Angus W Jeffrey, Leon A Adams
Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease. Alimentary pharmacology & therapeutics 58 (6) (2023)
Xiaojiao Wu, Yang Yang
Letter: Chinese herbal medicine Curcumin-QingDai (CurQD) - A good treatment option for active ulcerative colitis? Alimentary pharmacology & therapeutics 58 (6) (2023)
Feng Gao, Christopher D Byrne, Giovanni Targher, Shuangmu Zhuo, Ming-Hua Zheng, null null
Editorial: Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease-Authors' reply. Alimentary pharmacology & therapeutics 58 (6) (2023)
Yu Jun Wong
Letter: Baveno-VI criteria to exclude large varices in patients with hepatocellular carcinoma-What have we learned? Alimentary pharmacology & therapeutics 58 (6) (2023)
Axel U Dignass, Stefan Rath, Thomas Kleindienst, Andreas Stallmach
Editorial: If STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails-Authors' reply. Alimentary pharmacology & therapeutics 58 (6) (2023)
Saurabh Kedia, Vineet Ahuja
Editorial: If STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails. Alimentary pharmacology & therapeutics 58 (6) (2023)
Henit Yanai, Nir Salomon, Shomron Ben-Horin, Uri Kopylov
Letter: Chinese herbal medicine Curcumin-QingDai (CurQD)-A good treatment option for active ulcerative colitis? Authors' reply. Alimentary pharmacology & therapeutics 58 (6) (2023)

volume 58, number 7, 2023

volume 58, number 8, 2023

Meng-Hsuan Kuo, Chih-Wei Tseng, Shih-Chieh Shao
Letter: Incidence of hepatitis B virus reactivation in patients with psoriasis treated with cytokine inhibitors. Alimentary pharmacology & therapeutics 58 (8) (2023)
Ashkan Rezazadeh Ardabili, Adriaan A van Bodegraven
Editorial: IBD cost evolution - transitioning from compensating lost productivity to escalating medication expenses. Alimentary pharmacology & therapeutics 58 (8) (2023)
Bridgette Andrew, Annie Zhou, Steven Trinh, Ashish Srinivasan, Abhinav Vasudevan
Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed. Alimentary pharmacology & therapeutics 58 (8) (2023)
Hangfei Xu, Yang Zhang, Jing Zhang
Letter: NSBB for fatty liver disease-Still a long way to go. Alimentary pharmacology & therapeutics 58 (8) (2023)
Rafael Paternostro, Mathias Jachs, Thomas Reiberger, Mattias Mandorfer
Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease-Authors' reply. Alimentary pharmacology & therapeutics 58 (8) (2023)
Tessa Greeve, Ralley E Prentice, Edward Shelton, Ray Boyapati, Frauke Lever, Sally J Bell
Letter: Transperineal ultrasonography for ulcerative proctitis- Applicability in the pregnant population? Alimentary pharmacology & therapeutics 58 (8) (2023)
Shin Ju Oh, Hyo Jong Kim, Chang Kyun Lee
Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed-Authors' reply. Alimentary pharmacology & therapeutics 58 (8) (2023)
Mathias Jachs, Rafael Paternostro, Thomas Reiberger, Mattias Mandorfer
Letter: NSBB for fatty liver disease-Still a long way to go. Authors' reply. Alimentary pharmacology & therapeutics 58 (8) (2023)
Eiichi Ogawa
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy-Author's reply. Alimentary pharmacology & therapeutics 58 (8) (2023)
Robin C Spiller
Editorial: Interaction between fibre and colonic fermentation assessed with a novel gas-sensing capsule. Alimentary pharmacology & therapeutics 58 (8) (2023)
Jia-Yong Su, Ying-Ling Wu, Xuan-Lin Wu, Zhen-Xiu Liu, Yi-Yang Wang, Zhong-Hai Li, Jia-Xin Luo, Kun-Jun Wu, Jian-Hong Zhong
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy. Alimentary pharmacology & therapeutics 58 (8) (2023)
Elba Llop, Jose Luis Calleja
Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease. Alimentary pharmacology & therapeutics 58 (8) (2023)

volume 58, number 9, 2023

Elvira Lesmana, Madhusudan Grover
Editorial: Faecal microbiota transplantation in IBS-Moving closer or away from success? Alimentary pharmacology & therapeutics 58 (9) (2023)
Steven Trinh, Bridgette Andrew, Stephen Bloom, Rohit Sawhney
Letter: Consensus in international guidelines when discontinuing nucleos(t)ide analogue therapy in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 58 (9) (2023)
Jia-Jia Dong, Qiong-Ying Zhang, Yi-Jing Cai
Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Alimentary pharmacology & therapeutics 58 (9) (2023)
Grace Lai-Hung Wong, Vicki Wing-Ki Hui, Yee-Tak Hui, Chung Yan Grace Lui
Letter: Rethinking the lower incidence of HCC in HIV-infected patients-A closer look at confounding factors. Authors' reply. Alimentary pharmacology & therapeutics 58 (9) (2023)
Emily Walsh Lopes, Hamed Khalili
Editorial: Unravelling the fibres-low dietary fibre may lower risk of developing IBD. Alimentary pharmacology & therapeutics 58 (9) (2023)
Gong Feng, Yasser Mahrous Fouad, Ming-Hua Zheng
Letter: Detecting unreported alcohol consumption in patients with NAFLD-Standardisation is urgent. Alimentary pharmacology & therapeutics 58 (9) (2023)
Lintao Dan, Xiao-Yan Wang, Therese Hesketh
Editorial: Unravelling the fibres-low dietary fibre may lower risk of developing IBD. Authors' reply. Alimentary pharmacology & therapeutics 58 (9) (2023)
Josbert J Keller, Elisabeth M Terveer
Editorial: Continuous monitoring to improve outcome of treatment-the next step towards safe and effective faecal microbiota transplantation. Alimentary pharmacology & therapeutics 58 (9) (2023)
Guang-Zhao Shao, Wei Zhang, Yi-Fan Wu, Zhong-Qi Fan, Tian Yang, Guo-Yue Lv
Letter: Rethinking the lower incidence of HCC in HIV-infected patients- A closer look at confounding factors. Alimentary pharmacology & therapeutics 58 (9) (2023)
Jian Zhao
Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 58 (9) (2023)
Filipe S Cardoso, Minjee Kim, Rui Pereira, Luís Bagulho, Pedro Fidalgo, Anna Pawlowski, Richard Wunderink, Nuno Germano, Sean M Bagshaw, Juan G Abraldes, Constantine J Karvellas
Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' reply. Alimentary pharmacology & therapeutics 58 (9) (2023)
Rui Huang, Zhiyi Zhang, Jian Wang, Shaoqiu Zhang, Chao Wu
Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 58 (9) (2023)
Sander Lefere, Anja Geerts
Letter: Detecting unreported alcohol consumption in patients with NAFLD - Standardisation is urgent. Authors' reply. Alimentary pharmacology & therapeutics 58 (9) (2023)
Won-Mook Choi, Young Suk Lim
Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults. Alimentary pharmacology & therapeutics 58 (9) (2023)
Simon Mark Dahl Jørgensen, Mette Mejlby Hansen, Sara Ellegaard Andreasen, Marcel Kjaersgaard Eriksen, Nina Rågård, Jens Kelsen, Anne Karmisholt Grosen, Susan Mikkelsen, Christian Erikstrup, Jens Frederik Dahlerup, Christian Lodberg Hvas
Editorial: Continuous monitoring to improve outcome of treatment-the next step towards safe and effective faecal microbiota transplantation. Authors' reply. Alimentary pharmacology & therapeutics 58 (9) (2023)
Qi Su, Yuk K Yau, William K K Wu
Editorial: Faecal microbiota transplantation in IBS-Moving closer or away from success? Authors' reply. Alimentary pharmacology & therapeutics 58 (9) (2023)
Xiaoli Wu, Songxu Peng
Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults-authors' reply. Alimentary pharmacology & therapeutics 58 (9) (2023)